A Real-World Medical Chart Review of Spinal Muscular Atrophy Patients Treated With Onasemnogene Abeparvovec in Saudi Arabia
Clinical trial NCT07737756 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07737756
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-08-20
- Primary completion
- 2026-11-20
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.